Useful resources |
Tamoxifen for hepatocellular carcinoma (Cochrane Review) ABSTRACT Background: Hepatocellular carcinoma (primary liver cancer) is the third commonest cause of cancer mortality world-wide. Survival is poor for patients with advanced disease. Trials of tamoxifen for hepatocellular carcinoma have conflicting results. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |